Chief Executive Officer, Telix Precision Medicine
Appears in 1 story
Leading the division that won FDA approval for Pixclara
Brain cancer doctors face a maddening problem: after radiation and chemo, standard MRI scans often can't tell whether a suspicious spot is tumor regrowth or treatment-related change. The two scenarios call for opposite treatments. The FDA just approved a test that settles the question.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
